HomeCompareCHNXF vs DGRO

CHNXF vs DGRO: Dividend Comparison 2026

CHNXF yields 26490.07% · DGRO yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CHNXF wins by $856500661636595056640.00M in total portfolio value
10 years
CHNXF
CHNXF
● Live price
26490.07%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$856500661636595056640.00M
Annual income
$850,187,174,759,804,400,000,000,000.00
Full CHNXF calculator →
DGRO
iShares Core Dividend Growth ETF
● Live price
2.13%
Share price
$68.98
Annual div
$1.47
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.6K
Annual income
$239.96
Full DGRO calculator →

Portfolio growth — CHNXF vs DGRO

📍 CHNXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCHNXFDGRO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CHNXF + DGRO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CHNXF pays
DGRO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHNXF
Annual income on $10K today (after 15% tax)
$2,251,655.63/yr
After 10yr DRIP, annual income (after tax)
$722,659,098,545,833,800,000,000,000.00/yr
DGRO
Annual income on $10K today (after 15% tax)
$181.24/yr
After 10yr DRIP, annual income (after tax)
$203.97/yr
At 15% tax rate, CHNXF beats the other by $722,659,098,545,833,800,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHNXF + DGRO for your $10,000?

CHNXF: 50%DGRO: 50%
100% DGRO50/50100% CHNXF
Portfolio after 10yr
$428250330818297528320.00M
Annual income
$425,093,587,379,902,200,000,000,000.00/yr
Blended yield
99.26%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHNXF buys
0
DGRO buys
0
No recent congressional trades found for CHNXF or DGRO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCHNXFDGRO
Forward yield26490.07%2.13%
Annual dividend / share$2.00$1.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$856500661636595056640.00M$31.6K
Annual income after 10y$850,187,174,759,804,400,000,000,000.00$239.96
Total dividends collected$856084953147245199360.00M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: CHNXF vs DGRO ($10,000, DRIP)

YearCHNXF PortfolioCHNXF Income/yrDGRO PortfolioDGRO Income/yrGap
1← crossover$2,659,707$2,649,006.62$11,293$213.22+$2.65MCHNXF
2$661,311,349$658,465,463.27$12,730$217.32+$661.30MCHNXF
3$153,718,184,329$153,010,581,185.41$14,326$221.10+$153718.17MCHNXF
4$33,404,167,863,182$33,239,689,405,949.67$16,098$224.56+$33404167.85MCHNXF
5$6,786,439,075,574,744$6,750,696,615,961,140.00$18,064$227.74+$6786439075.56MCHNXF
6$1,289,019,706,709,597,000$1,281,758,216,898,732,000.00$20,246$230.65+$1289019706709.58MCHNXF
7$228,909,915,433,776,940,000$227,530,664,347,597,670,000.00$22,666$233.30+$228909915433776.91MCHNXF
8$38,007,474,205,860,660,000,000$37,762,540,596,346,516,000,000.00$25,349$235.73+$38007474205860656.00MCHNXF
9$5,900,455,025,037,820,000,000,000$5,859,787,027,637,549,000,000,000.00$28,325$237.94+$5900455025037819904.00MCHNXF
10$856,500,661,636,595,100,000,000,000$850,187,174,759,804,400,000,000,000.00$31,624$239.96+$856500661636595056640.00MCHNXF

CHNXF vs DGRO: Complete Analysis 2026

CHNXFStock

ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.

Full CHNXF Calculator →

DGROETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →
📬

Get this CHNXF vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHNXF vs SCHDCHNXF vs JEPICHNXF vs OCHNXF vs KOCHNXF vs MAINCHNXF vs VIGCHNXF vs NOBLCHNXF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.